Actieve functies van Alan R. Meyer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Directeur/Bestuurslid | 01-01-2018 | - |
| Oprichter | 01-01-2002 | - | |
| Algemeen Directeur | 01-01-2002 | 01-01-2018 |
Loopbaan van Alan R. Meyer
Eerdere bekende functies van Alan R. Meyer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Directeur/Bestuurslid | - | 07-06-2021 |
| Oprichter | 01-02-2018 | 07-06-2021 | |
| AKSYS LTD. | Directeur/Bestuurslid | - | 23-06-2006 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Directeur/Bestuurslid | 01-01-1992 | 01-01-2000 |
| Financieel Directeur/CFO | 01-01-1992 | 01-01-2000 |
Opleiding van Alan R. Meyer
| University of Illinois | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director/Board Member | 4 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AKSYS LTD. | Finance |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
- Beurs
- Insiders
- Alan R. Meyer
- Ervaring
